NCT00004635 2018-05-22Thalidomide for the Treatment of Hormone-Dependent Prostate CancerNational Institutes of Health Clinical Center (CC)Phase 3 Completed159 enrolled 9 charts
NCT00248547 2017-05-09Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantOHSU Knight Cancer InstitutePhase NA Completed40 enrolled 8 charts